サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1720556

ギランバレー症候群（GBS）診断の世界市場 - 市場規模、シェア、動向、産業分析：検査別、最終用途別、地域別 - 市場予測（2025年～2034年）

Guillain-Barre Syndrome Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Test, End Use, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 125 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
ギランバレー症候群（GBS）診断の世界市場 - 市場規模、シェア、動向、産業分析：検査別、最終用途別、地域別 - 市場予測（2025年～2034年）
出版日: 2025年04月01日
発行: Polaris Market Research
ページ情報: 英文 125 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のギランバレー症候群（GBS）診断の市場規模は、2034年までに1億9,071万米ドルに達する見込みです。

ギランバレー症候群（GBS）の診断では、この末梢神経系に影響を及ぼす希少な自己免疫疾患の存在を確認するために、臨床評価と神経伝導検査や腰椎穿刺などの検査を組み合わせて行います。

医療診断の技術的進歩がGBS診断市場の成長を促進しています。高解像度の神経伝導検査や改良された腰椎穿刺など、より新しく洗練されたツールにより、医療従事者は以前よりも正確かつ迅速にGBSを診断できるようになっています。こうした開発により、誤診の可能性が減少し、治療が遅れて患者の状態が悪化することが少なくなっています。さらに、革新的な診断プラットフォームは、患者にも医療従事者にも、非侵襲性のより迅速かつ安価な選択肢を提供し、GBSの効果的な特定と治療を容易にしています。こうした継続的な技術革新が、ギランバレー症候群（GBS）診断市場の拡大を促進しています。

医学研究への資金提供の増加は、ギランバレー症候群（GBS）診断市場の動向に大きな影響を与えています。政府、民間団体、医療機関は、ギランバレー症候群（GBS）やその原因の研究、診断効率の向上に、より多くのリソースを投資しています。こうした投資により、診断の精度を高め、診断時間を短縮する新しい手法、ツール、技術が開発されています。また、研究資金の提供によりGBSに対する理解が深まり、より効果的な検出戦略につながっています。GBS研究への資金援助は、引き続き先進の診断ソリューションの利用可能性を促進しており、早期の発見と治療が患者にとってより身近なものとなっています。

ギランバレー症候群（GBS）診断市場レポートのハイライト

最終用途別では、GBS診断に必要なリソースを利用できることから、病院・診療所セグメントが2024年のギランバレー症候群（GBS）診断の市場シェアを独占しました。

検査別では、脳脊髄液のタンパク質濃度の上昇を分析することでGBSの診断に役立つ重要な検査であることから、腰椎穿刺セグメントが予測期間にもっとも急速に成長する見込みです。

2024年、北米がGBS診断市場の収益シェアを独占しました。これは先進の医療インフラと希少疾患に対する高い認知度によるものです。

アジア太平洋は、医療インフラの改良と希少疾患に対する意識の高まりにより、予測期間に大きなシェアを記録する見込みです。

世界の主な市場参入企業は、Alpine Biomed、Bionen Medical Devices、Cadwell Industries, Inc、Deymed Diagnostic、EMS Biomedical、Medtronic plc、Natus Medical Incorporated、Neurosoft、Nihon Kohden Corporation、Rochester Electro-Medical, Inc.などです。

当レポートでは、世界のギランバレー症候群（GBS）診断市場について調査し、現在の市場力学の詳細な考察や、将来の市場成長に関する分析を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のギランバレー症候群（GBS）診断市場の考察

  • 市場スナップショット
  • ギランバレー症候群（GBS）診断の市場力学
    • 促進要因と機会
      • 老年人口の増加
      • ギランバレー症候群（GBS）の有病率の上昇
    • 抑制要因と課題
      • 熟練労働者の不足
  • PESTEL分析
  • ギランバレー症候群（GBS）診断市場の最終用途動向
  • バリューチェーン分析
  • COVID-19の影響の分析

第5章 世界のギランバレー症候群（GBS）診断市場：検査別

  • 主な調査結果
  • イントロダクション
  • 腰椎穿刺
  • 神経伝導
  • 筋電図検査
  • その他

第6章 世界のギランバレー症候群（GBS）診断市場：最終用途別

  • 主な調査結果
  • イントロダクション
  • 病院・診療所
  • 診断研究所
  • その他

第7章 世界のギランバレー症候群（GBS）診断市場：地域別

  • 主な調査結果
  • イントロダクション
    • ギランバレー症候群（GBS）診断市場の分析：地域別（2020年～2034年）
  • 北米
    • 北米：テスト別（2020年～2034年）
    • 北米：最終用途別（2020年～2034年）
    • 米国
    • カナダ
  • 欧州
    • 欧州：テスト別（2020年～2034年）
    • 欧州：最終用途別（2020年～2034年）
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他の欧州
  • アジア太平洋
    • アジア太平洋：テスト別（2020年～2034年）
    • アジア太平洋：最終用途別（2020年～2034年）
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他のアジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ：テスト別（2020年～2034年）
    • 中東・アフリカ：最終用途別（2020年～2034年）
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：テスト別（2020年～2034年）
    • ラテンアメリカ：最終用途別（2020年～2034年）
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他のラテンアメリカ

第8章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • パートナーシップ/協業/合意/公開

第9章 企業プロファイル

  • Alpine Biomed
  • Bionen Medical Devices
  • Cadwell Industries, Inc
  • Deymed Diagnostic
  • EMS Biomedical
  • Medtronic plc
  • Natus Medical Incorporated
  • Neurosoft
  • Nihon Kohden Corporation
  • Rochester Electro-Medical, Inc.
図表

List of Tables:

  • Table 1 Global Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 2 Global Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 3 North America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 4 North America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 5 U.S.: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 6 U.S.: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 7 Canada: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 8 Canada: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 9 Europe: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 10 Europe: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 11 UK: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 12 UK: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 13 France: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 14 France: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 15 Germany: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 16 Germany: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 17 Italy: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 18 Italy: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 19 Spain: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 20 Spain: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 21 Netherlands: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 22 Netherlands: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 23 Russia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 24 Russia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 25 Rest of Europe: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 26 Rest of Europe: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 27 Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 28 Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 29 China: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 30 China: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 31 India: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 32 India: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 33 Malaysia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 34 Malaysia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 35 Japan: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 36 Japan: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 37 Indonesia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 38 Indonesia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 39 South Korea: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 40 South Korea: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 41 Australia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 42 Australia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 43 Rest of Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 44 Rest of Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 45 Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 46 Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 47 Saudi Arabia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 48 Saudi Arabia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 49 UAE: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 50 UAE: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 51 Israel: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 52 Israel: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 53 South Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 54 South Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 55 Rest of Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 56 Rest of Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 57 Latin America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 58 Latin America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 59 Mexico: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 60 Mexico: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 61 Brazil: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 62 Brazil: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 63 Argentina: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 64 Argentina: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • Table 65 Rest of Latin America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • Table 66 Rest of Latin America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Guillain-Barre Syndrome Diagnostics Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Test
  • Figure 7. Global Guillain-Barre Syndrome Diagnostics Market, by Test, 2024 & 2034 (USD Million)
  • Figure 8. Market by End Use
  • Figure 9. Global Guillain-Barre Syndrome Diagnostics Market, by End Use, 2024 & 2034 (USD Million)
目次
Product Code: PM5538

The Guillain-Barre syndrome (GBS) diagnostics market size is expected to reach USD 190.71 million by 2034, according to a new study by Polaris Market Research. The report "Guillain-Barre Syndrome Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Test (Lumber Puncture, Nerve Conduction, Electromyography, and Others), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Guillain-Barre Syndrome (GBS) diagnostics involves a combination of clinical evaluation and tests such as nerve conduction studies and lumbar puncture to confirm the presence of this rare autoimmune disorder affecting the peripheral nervous system.

Technological advancements in medical diagnostics are driving the GBS diagnostics market growth. Newer, more sophisticated tools such as high-resolution nerve conduction studies and improved lumbar punctures allow healthcare professionals to diagnose GBS more accurately and faster than before. These developments have reduced the chances of misdiagnosis, which delay treatment and worsen the patient's condition. Moreover, innovative diagnostic platforms now offer noninvasive, quicker, and more affordable options for both patients and healthcare providers, making it easier to identify and treat GBS effectively. These ongoing innovations are driving the Guillain-Barre syndrome diagnostics market expansion.

Increasing funding for medical research has significantly impacted the Guillain-Barre Syndrome diagnostics market trends. Governments, private organizations, and healthcare institutions are investing more resources into studying GBS, its causes, and improving diagnostic efficiency. These investments have led to the development of new methods, tools, and technologies that improve accuracy and reduce diagnosis time. Research funding has also deepened the understanding of the disease, leading to more effective detection strategies. Financial support for GBS research continues to drive the availability of advanced diagnostic solutions, making early detection and treatment more accessible to patients.

Guillain-Barre Syndrome Diagnostics Market Report Highlights

Based on end use, the hospital and clinics segment dominated the Guillain-Barre syndrome diagnostics market share in 2024 due to the availability of the required resources for the diagnosis of GBS.

The lumber puncture segment, by test, is expected to witness the fastest growth during the forecast period as it is a critical test that helps diagnose GBS by analyzing the cerebrospinal fluid for elevated protein levels.

In 2024, North America dominated the GBS diagnostics market revenue share, driven by advanced healthcare infrastructure and high awareness of rare diseases.

Asia Pacific is expected to record a significant share during the forecast period, due to improving healthcare infrastructure and increasing awareness of rare diseases.

A few global key market players are Alpine Biomed; Bionen Medical Devices; Cadwell Industries, Inc; Deymed Diagnostic; EMS Biomedical; Medtronic plc; Natus Medical Incorporated; Neurosoft; Nihon Kohden Corporation; and Rochester Electro-Medical, Inc.

Polaris Market Research has segmented the Guillain-Barre syndrome diagnostics market report on the basis of test, end use, and region:

By Test (Revenue - USD Million, 2020-2034)

  • Lumbar Puncture
  • Nerve Conduction
  • Electromyography
  • Other

By End Use (Revenue - USD Million, 2020-2034)

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Guillain-Barre Syndrome Diagnostics Market Insights

  • 4.1. Guillain-Barre Syndrome Diagnostics Market - Market Snapshot
  • 4.2. Guillain-Barre Syndrome Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Geriatric Population
      • 4.2.1.2. Rising Prevalence of Guillain-Barre Syndrome
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of Skilled Workforce
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Guillain-Barre Syndrome Diagnostics Market End Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Guillain-Barre Syndrome Diagnostics Market, by Test

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
  • 5.3. Lumbar Puncture
    • 5.3.1. Global Guillain-Barre Syndrome Diagnostics Market, by Lumbar Puncture, by Region, 2020-2034 (USD Million)
  • 5.4. Nerve Conduction
    • 5.4.1. Global Guillain-Barre Syndrome Diagnostics Market, by Nerve Conduction, by Region, 2020-2034 (USD Million)
  • 5.5. Electromyography
    • 5.5.1. Global Guillain-Barre Syndrome Diagnostics Market, by Electromyography, by Region, 2020-2034 (USD Million)
  • 5.6. Other
    • 5.6.1. Global Guillain-Barre Syndrome Diagnostics Market, by Other, by Region, 2020-2034 (USD Million)

6. Global Guillain-Barre Syndrome Diagnostics Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 6.3. Hospitals and Clinics
    • 6.3.1. Global Guillain-Barre Syndrome Diagnostics Market, by Hospitals and Clinics, by Region, 2020-2034 (USD Million)
  • 6.4. Diagnostic Laboratories
    • 6.4.1. Global Guillain-Barre Syndrome Diagnostics Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Guillain-Barre Syndrome Diagnostics Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Guillain-Barre Syndrome Diagnostics Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Guillain-Barre Syndrome Diagnostics Market Assessment, By Geography, 2020-2034 (USD Million)
  • 7.3. Guillain-Barre Syndrome Diagnostics Market - North America
    • 7.3.1. North America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 7.3.2. North America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.3.3. Guillain-Barre Syndrome Diagnostics Market - U.S.
      • 7.3.3.1. U.S.: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.3.3.2. U.S.: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.3.4. Guillain-Barre Syndrome Diagnostics Market - Canada
      • 7.3.4.1. Canada: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.3.4.2. Canada: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 7.4. Guillain-Barre Syndrome Diagnostics Market - Europe
    • 7.4.1. Europe: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 7.4.2. Europe: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.3. Guillain-Barre Syndrome Diagnostics Market - UK
      • 7.4.3.1. UK: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.3.2. UK: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.4. Guillain-Barre Syndrome Diagnostics Market - France
      • 7.4.4.1. France: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.4.2. France: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.5. Guillain-Barre Syndrome Diagnostics Market - Germany
      • 7.4.5.1. Germany: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.5.2. Germany: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.6. Guillain-Barre Syndrome Diagnostics Market - Italy
      • 7.4.6.1. Italy: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.6.2. Italy: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.7. Guillain-Barre Syndrome Diagnostics Market - Spain
      • 7.4.7.1. Spain: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.7.2. Spain: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.8. Guillain-Barre Syndrome Diagnostics Market - Netherlands
      • 7.4.8.1. Netherlands: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.8.2. Netherlands: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.9. Guillain-Barre Syndrome Diagnostics Market - Russia
      • 7.4.9.1. Russia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.9.2. Russia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.4.10. Guillain-Barre Syndrome Diagnostics Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.4.10.2. Rest of Europe: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 7.5. Guillain-Barre Syndrome Diagnostics Market - Asia Pacific
    • 7.5.1. Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 7.5.2. Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.3. Guillain-Barre Syndrome Diagnostics Market - China
      • 7.5.3.1. China: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.3.2. China: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.4. Guillain-Barre Syndrome Diagnostics Market - India
      • 7.5.4.1. India: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.4.2. India: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.5. Guillain-Barre Syndrome Diagnostics Market - Malaysia
      • 7.5.5.1. Malaysia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.5.2. Malaysia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.6. Guillain-Barre Syndrome Diagnostics Market - Japan
      • 7.5.6.1. Japan: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.6.2. Japan: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.7. Guillain-Barre Syndrome Diagnostics Market - Indonesia
      • 7.5.7.1. Indonesia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.7.2. Indonesia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.8. Guillain-Barre Syndrome Diagnostics Market - South Korea
      • 7.5.8.1. South Korea: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.8.2. South Korea: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.9. Guillain-Barre Syndrome Diagnostics Market - Australia
      • 7.5.9.1. Australia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.9.2. Australia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.5.10. Guillain-Barre Syndrome Diagnostics Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.5.10.2. Rest of Asia Pacific: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 7.6. Guillain-Barre Syndrome Diagnostics Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 7.6.2. Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.6.3. Guillain-Barre Syndrome Diagnostics Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.6.3.2. Saudi Arabia: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.6.4. Guillain-Barre Syndrome Diagnostics Market - UAE
      • 7.6.4.1. UAE: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.6.4.2. UAE: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.6.5. Guillain-Barre Syndrome Diagnostics Market - Israel
      • 7.6.5.1. Israel: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.6.5.2. Israel: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.6.6. Guillain-Barre Syndrome Diagnostics Market - South Africa
      • 7.6.6.1. South Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.6.6.2. South Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.6.7. Guillain-Barre Syndrome Diagnostics Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.6.7.2. Rest of Middle East & Africa: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
  • 7.7. Guillain-Barre Syndrome Diagnostics Market - Latin America
    • 7.7.1. Latin America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
    • 7.7.2. Latin America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.7.3. Guillain-Barre Syndrome Diagnostics Market - Mexico
      • 7.7.3.1. Mexico: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.7.3.2. Mexico: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.7.4. Guillain-Barre Syndrome Diagnostics Market - Brazil
      • 7.7.4.1. Brazil: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.7.4.2. Brazil: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.7.5. Guillain-Barre Syndrome Diagnostics Market - Argentina
      • 7.7.5.1. Argentina: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.7.5.2. Argentina: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)
    • 7.7.6. Guillain-Barre Syndrome Diagnostics Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Guillain-Barre Syndrome Diagnostics Market, by Test, 2020-2034 (USD Million)
      • 7.7.6.2. Rest of Latin America: Guillain-Barre Syndrome Diagnostics Market, by End Use, 2020-2034 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Alpine Biomed
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Bionen Medical Devices
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Cadwell Industries, Inc
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Deymed Diagnostic
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. EMS Biomedical
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Medtronic plc
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Natus Medical Incorporated
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Neurosoft
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Nihon Kohden Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Rochester Electro-Medical, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development